Willow Innovations

Telehealth platform coordinating caregivers, families, professionals

Willow Innovations

Telehealth platform coordinating caregivers, families, professionals

Overview

Willow Innovations provides a telehealth platform designed to improve caregiving by connecting caregivers, family members, and healthcare professionals. It supports real-time video consultations, secure messaging, and comprehensive care management for both in-home and institutional care settings. The platform offers a user-friendly interface with features like personalized care plans, progress tracking, and streamlined communication to ensure all stakeholders have up-to-date information and can collaborate effectively. What sets the platform apart is its focus on bridging the gap between caregivers and healthcare systems, creating a connected caregiving network that is easy to use for both clinical staff and family members. The company’s goal is to enhance health outcomes by enhancing coordination and communication across the caregiving ecosystem.

Work here?Claim your company

About Willow Innovations

Simplify's Rating

Why Willow Innovations is rated

C+

Rated B on Competitive Edge

Rated B on Growth Potential

Rated D+ on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareHealthcare

Company Size

51-200

Company Stage

Series C

Total Funding

$146.8M

Headquarters

Mountain View, CA

Founded

2014

Get referred to Willow Innovations

See people who can refer or advise you

Simplify's take

What believers are saying

Willow launched Willow World on October 27, 2026, expanding education and community.
Target nationwide distribution keeps Willow in front of high-intent postpartum shoppers.
The Women’s Health AI Consortium strengthens Willow’s credibility around clinical AI standards.

What critics are saying

The September 2026 ITC case can block rival imports, escalating patent warfare.
FDA MAUDE logged a serious WILLOW 360 failure on June 30, 2025.
A 2026 replacement or warranty scandal could destroy trust in a postpartum-category brand.

What makes Willow Innovations unique

Willow owns wearable breast-pump hardware, software, and postpartum support in one stack.
The 2025 Elvie acquisition broadened Willow into pelvic tools and global maternal products.
The 2026 Swehl and Momtech deals add community, education, and feeding technology.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$146.8M

Below

Industry Average

Funded Over

6 Rounds

Notable Investors:

Founders Fund

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.

Series C Funding Comparison

Below Average

Industry standards

Ind Avg. $50M

$40M

$50M

$62M

$100M

Company News

MedCity News

Oct 27th, 2026

Willow Acquires 2 Women’s Health Companies - MedCity News

Willow Innovations acquired Swehl and Momtech to expand its maternal health offerings beyond breast pumps.

Business Wire

May 12th, 2026

Health leaders launch Women's Health AI Consortium to set ethical standards

Willow Innovations and Ema EQ have launched the Women's Health AI Consortium, the first industry body dedicated to establishing standards and ethical guidelines for AI in women's health. The consortium addresses the historic underinvestment in women's health technology, where AI tools are often built on incomplete data and deployed without sufficient oversight. The initiative is governed by a multidisciplinary board including clinicians, technologists and ethicists. It operates around six core commitments focused on accuracy benchmarks, data transparency and clinical validation. The consortium aims to ensure AI tools reflect women's lived experiences and meet safety standards before widespread deployment. "Women's health AI is moving at a pace that demands immediate, coordinated accountability," says Sarah O'Leary, CEO of Willow. The consortium provides shared standards for organisations developing or deploying AI in women's health.

PR Newswire

Mar 24th, 2026

Willow launches 7 breastfeeding essentials at Target nationwide to expand maternal care access

Willow, a maternal health company known for wearable breast pumps, has launched seven new breastfeeding essentials now available at Target stores nationwide. The expanded collection complements its existing pump line and aims to make postpartum care more accessible. The new products include a Breast Milk Cooler in two sizes, breast milk storage bags featuring SmartStash technology for tracking milk supplies via app, and the Willow Wave 2-in-1 double manual pump. The collection also offers sizing kits, care kits and colostrum collection supplies, all developed with clinical input from lactation consultants. Founded in 2014, Willow first debuted its breastfeeding essentials collection in 2023. The company's maternal care platform combines products with educational support, including free lactation consultations and feeding courses for postpartum parents.

PR Newswire

Apr 29th, 2025

Willow Partners With Canopie To Donate 1 Million Hours Of Maternal Mental Health Support To Kick Off Its Mother'S Day Campaign

1 in 5 women experience Perinatal Mood and Anxiety Disorders; Partnership addresses the critical need for mental wellness resources, offering free personalized, virtual mental health servicesSAN FRANCISCO, April 22, 2025 /PRNewswire/ -- Willow Innovations, Inc. (Willow), the FemTech leader that revolutionized the breast pumping experience by inventing the first fully in-bra wearable breast pump, announces today its commitment to provide 1 million hours of maternal mental health support to new mothers nationwide. Willow is partnering with Canopie , the preventive maternal health care platform, to offer personalized, virtual mental health services.According to Postpartum Support International, one in five women experiences Perinatal Mood and Anxiety Disorders (PMADs) during pregnancy and postpartum. PMADs are the most common complication of childbirth1. Yet, only 15 percent of women with PMADs are treated, making it the most underdiagnosed and inadequately treated obstetric complication in the United States2. Willow's partnership with Canopie will help ensure that mothers can access expert, evidence-based care and guidance to help them thrive during their postpartum journey

Femtech Insider

Mar 28th, 2025

Willow Acquires Elvie Amid Administration

Willow Innovations has acquired UK-based femtech company Elvie, which was in administration, marking a significant development in maternal health technology. The acquisition combines Willow's medical device technology with Elvie's products, including breast pumps and smart pelvic tools. Both companies have pioneered wearable breast pump technology, now 57% of the US market. The acquisition aims to enhance maternal health solutions and continue innovating for mothers globally.

Recently Posted Jobs